NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Market Source Research released its latest key findings for all current investors, traders, and shareholders of American Tower
Corporation (REIT) (NYSE:AMT), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA),
Cummins Inc. (NYSE:CMI), Alexander's, Inc. (NYSE:ALX), and Korea Electric Power Corporation (NYSE:KEP), including updated
fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
AMT DOWNLOAD: http://MarketSourceResearch.com/register/?so=AMT
LGND DOWNLOAD: http://MarketSourceResearch.com/register/?so=LGND
TEVA DOWNLOAD: http://MarketSourceResearch.com/register/?so=TEVA
CMI DOWNLOAD: http://MarketSourceResearch.com/register/?so=CMI
ALX DOWNLOAD: http://MarketSourceResearch.com/register/?so=ALX
KEP DOWNLOAD: http://MarketSourceResearch.com/register/?so=KEP
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine
American Tower Corporation (REIT) (NYSE:AMT), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Teva Pharmaceutical Industries
Ltd. (NYSE:TEVA), Cummins Inc. (NYSE:CMI), Alexander's, Inc. (NYSE:ALX), and Korea Electric Power Corporation (NYSE:KEP) on a
fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business
strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are
available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed November 27th,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
AMERICAN TOWER CORPORATION (REIT) (AMT) REPORT OVERVIEW
American Tower Corporation (REIT)'s Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, American Tower Corporation (REIT)
reported revenue of $1,785.50MM vs $1,680.70MM (up 6.24%) and analysts estimated basic earnings per share $0.83 vs $0.70 (up
18.57%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, American Tower Corporation (REIT) reported revenue
of $6,663.90MM vs $5,785.70MM (up 15.18%) and analysts estimated basic earnings per share $2.69 vs $2.00 (up 34.50%). Analysts
expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The
reported EPS for the same quarter last year was $1.59. The estimated EPS forecast for the next fiscal year is $7.71 and is expected
to report on February 26th, 2019.
To read the full American Tower Corporation (REIT) (AMT) report, download it here: http://MarketSourceResearch.com/register/?so=AMT
-----------------------------------------
LIGAND PHARMACEUTICALS INCORPORATED (LGND) REPORT OVERVIEW
Ligand Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Ligand Pharmaceuticals reported revenue
of $45.66MM vs $33.38MM (up 36.82%) and analysts estimated basic earnings per share $3.19 vs $0.40 (up 697.50%). For the twelve
months ended December 31st, 2017 vs December 31st, 2016, Ligand Pharmaceuticals reported revenue of $141.10MM vs $108.97MM (up
29.48%) and analysts estimated basic earnings per share $0.60 vs -$0.08. Analysts expect earnings to be released on February 20th,
2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.03.
The estimated EPS forecast for the next fiscal year is $4.61 and is expected to report on February 20th, 2019.
To read the full Ligand Pharmaceuticals Incorporated (LGND) report, download it here: http://MarketSourceResearch.com/register/?so=LGND
-----------------------------------------
TEVA PHARMACEUTICAL INDUSTRIES LTD. (TEVA) REPORT OVERVIEW
Teva Pharmaceutical Industries' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Teva Pharmaceutical Industries reported
revenue of $4,529.00MM vs $5,617.00MM (down 19.37%) and analysts estimated basic earnings per share -$0.27 vs $0.52. For the twelve
months ended December 31st, 2017 vs December 31st, 2016, Teva Pharmaceutical Industries reported revenue of $22,385.00MM vs
$21,903.00MM (up 2.20%) and analysts estimated basic earnings per share -$16.26 vs $0.07. Analysts expect earnings to be released
on February 14th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last
year was $0.91. The estimated EPS forecast for the next fiscal year is $2.68 and is expected to report on February 14th, 2019.
To read the full Teva Pharmaceutical Industries Ltd. (TEVA) report, download it here: http://MarketSourceResearch.com/register/?so=TEVA
-----------------------------------------
CUMMINS INC. (CMI) REPORT OVERVIEW
Cummins' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Cummins reported revenue of $5,943.00MM
vs $5,285.00MM (up 12.45%) and basic earnings per share $4.29 vs $2.72 (up 57.72%). For the twelve months ended December 31st, 2017
vs December 31st, 2016, Cummins reported revenue of $20,428.00MM vs $17,509.00MM (up 16.67%) and analysts estimated basic earnings
per share $5.99 vs $8.25 (down 27.39%). Analysts expect earnings to be released on February 5th, 2019. The report will be for the
fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $3.03. The estimated EPS forecast for
the next fiscal year is $15.58 and is expected to report on February 5th, 2019.
To read the full Cummins Inc. (CMI) report, download it here: http://MarketSourceResearch.com/register/?so=CMI
-----------------------------------------
ALEXANDER'S, INC. (ALX) REPORT OVERVIEW
Alexander's' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Alexander's reported revenue of
$59.13MM vs $58.09MM (up 1.77%) and analysts estimated basic earnings per share $2.93 vs $3.97 (down 26.20%). For the twelve months
ended December 31st, 2017 vs December 31st, 2016, Alexander's reported revenue of $230.57MM vs $226.94MM (up 1.60%) and analysts
estimated basic earnings per share $15.74 vs $16.91 (down 6.92%). Analysts expect earnings to be released on February 11th, 2019.
The report will be for the fiscal period ending December 31st, 2018.
To read the full Alexander's, Inc. (ALX) report, download it here: http://MarketSourceResearch.com/register/?so=ALX
-----------------------------------------
KOREA ELECTRIC POWER CORPORATION (KEP) REPORT OVERVIEW
Korea Electric Power's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Korea Electric Power reported revenue of
$12,003.44MM vs $11,632.99MM (up 3.18%) and analysts estimated basic earnings per share -$0.67 vs $0.46. For the twelve months
ended December 31st, 2017 vs December 31st, 2016, Korea Electric Power reported revenue of $53,402.30MM vs $53,786.78MM (down
0.71%) and analysts estimated basic earnings per share $0.91 vs $4.94 (down 81.57%). Analysts expect earnings to be released on
December 17th, 2018. The report will be for the fiscal period ending September 30th, 2018. The estimated EPS forecast for the next
fiscal year is $0.83 and is expected to report on January 30th, 2019.
To read the full Korea Electric Power Corporation (KEP) report, download it here: http://MarketSourceResearch.com/register/?so=KEP
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers,
professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team
is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA®
BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source
Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on
individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well
as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside
audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by
E-mail at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source
Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that
result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness
of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated
for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial
advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration.
For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com
© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
